Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.
Collaborating with some of the world’s largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization.
Our proprietary transdermal technologies are designed to deliver both small and large molecule therapeutics, potentially enabling the development of innovative products that could provide significant clinical and commercial advantages, including valuable product life cycle management.
